Transcriptomic and proteomic profiling reveals distinct pathogenic features of peripheral non-classical monocytes in systemic lupus erythematosus

被引:10
作者
Stergioti, Eirini Maria [1 ]
Manolakou, Theodora [1 ]
Sentis, George [1 ]
Samiotaki, Martina [1 ,3 ]
Kapsala, Noemin [2 ]
Fanouriakis, Antonis [2 ]
Boumpas, Dimitrios T. [1 ]
Banos, Aggelos [1 ]
机构
[1] Biomed Res Fdn Acad Athens, Ctr Clin Expt Surg & Translat Res, Lab Autoimmun & Inflammat, Athens 11527, Greece
[2] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Dept Internal Med, Med Sch, Athens 12462, Greece
[3] Biomed Sci Res Ctr Alexander Fleming, Inst BioInnovat, Vari Athens, Greece
基金
欧洲研究理事会;
关键词
Systemic lupus erythematosus; Non-classical monocytes; M1; macrophages; Cytokines; Cell cycle; Differentiation; POLARIZATION; MACROPHAGES; EXPRESSION; P53; DIFFERENTIATION; TRANSITION; SIGNATURES; SEVERITY; PATHWAY; LESIONS;
D O I
10.1016/j.clim.2023.109765
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Peripheral blood monocytes propagate inflammation in systemic lupus erythematosus (SLE). Three major populations of monocytes have been recognized namely classical (CM), intermediate (IM) and non-classical monocytes (NCM). Herein, we performed a comprehensive transcriptomic, proteomic and functional characterization of the three peripheral monocytic subsets from active SLE patients and healthy individuals. Our data demonstrate extensive molecular disruptions in circulating SLE NCM, characterized by enhanced inflammatory features such as deregulated DNA repair, cell cycle and heightened IFN signaling combined with differentiation and developmental cues. Enhanced DNA damage, elevated expression of p53, G0 arrest of cell cycle and increased autophagy stress the differentiation potential of NCM in SLE. This immunogenic profile is associated with an activated macrophage phenotype of NCM exhibiting M1 characteristics in the circulation, fueling the inflammatory response. Together, these findings identify circulating SLE NCM as a pathogenic cell type in the disease that could represent an additional therapeutic target.
引用
收藏
页数:16
相关论文
共 92 条
  • [51] Nonclassical Ly6C- Monocytes Drive the Development of Inflammatory Arthritis in Mice
    Misharin, Alexander V.
    Cuda, Carla M.
    Saber, Rana
    Turner, Jason D.
    Gierut, Angelica K.
    Haines, G. Kenneth, III
    Berdnikovs, Sergejs
    Filer, Andrew
    Clark, Andrew R.
    Buckley, Christopher D.
    Mutlu, Goekhan M.
    Budinger, G. R. Scott
    Perlman, Harris
    [J]. CELL REPORTS, 2014, 9 (02): : 591 - 604
  • [52] Transcriptional Control of Macrophage Identity, Self-Renewal, and Function
    Molawi, Kaaweh
    Sieweke, Michael H.
    [J]. DEVELOPMENT AND FUNCTION OF MYELOID SUBSETS, 2013, 120 : 269 - 300
  • [53] Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular Diseases
    Moschetti, Liala
    Piantoni, Silvia
    Vizzardi, Enrico
    Sciatti, Edoardo
    Riccardi, Mauro
    Franceschini, Franco
    Cavazzana, Ilaria
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [54] Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients
    Murayama, Goh
    Chiba, Asako
    Kuga, Taiga
    Makiyama, Ayako
    Yamaji, Ken
    Tamura, Naoto
    Miyake, Sachiko
    [J]. RHEUMATOLOGY, 2020, 59 (10) : 2992 - 3002
  • [55] Fractalkine expression and CD16+ monocyte accumulation in glomerular lesions: association with their severity and diversity in lupus models
    Nakatani, Kimihiko
    Yoshimoto, Shuhei
    Iwano, Masayuki
    Asai, Osamu
    Samejima, Ken-ichi
    Sakan, Hirokazu
    Terada, Miho
    Hasegawa, Hitoshi
    Nose, Masato
    Saito, Yoshihiko
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2010, 299 (01) : F207 - F216
  • [56] Mapping systemic lupus erythematosus heterogeneity at the single-cell level
    Nehar-Belaid, Djamel
    Hong, Seunghee
    Marches, Radu
    Chen, Guo
    Bolisetty, Mohan
    Baisch, Jeanine
    Walters, Lynnette
    Punaro, Marilynn
    Rossi, Robert J.
    Chung, Cheng-Han
    Huynh, Richie P.
    Singh, Prashant
    Flynn, William F.
    Tabanor-Gayle, Joy-Ann
    Kuchipudi, Navya
    Mejias, Asuncion
    Collet, Magalie A.
    Lucido, Anna Lisa
    Palucka, Karolina
    Robson, Paul
    Lakshminarayanan, Santhanam
    Ramilo, Octavio
    Wright, Tracey
    Pascual, Virginia
    Banchereau, Jacques F.
    [J]. NATURE IMMUNOLOGY, 2020, 21 (09) : 1094 - +
  • [57] RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis
    Ning Huangfu
    Zheng, Wenyuan
    Xu, Zhenyu
    Wang, Shenghuang
    Wang, Yong
    Cheng, Jingsong
    Li, Zhenwei
    Cheng, Ke'ai
    Zhang, Shuangshuang
    Chen, Xiaomin
    Zhu, Jianhua
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83
  • [58] Activation of the Mechanistic Target of Rapamycin in SLE: Explosion of Evidence in the Last Five Years
    Oaks, Zachary
    Winans, Thomas
    Huang, Nick
    Banki, Katalin
    Perl, Andras
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (12)
  • [59] Orekhov A.N., 2019, Vessel Plus, V3, P10, DOI [DOI 10.20517/2574-1209.2019.04, 10.20517/2574-1209.2019.04]
  • [60] DNA damage responses and p53 in the aging process
    Ou, Hui-Ling
    Schumacher, Bjoe
    [J]. BLOOD, 2018, 131 (05) : 488 - 495